Advanced search
Publication Cover
Modern Rheumatology Volume 20, 2010 - Issue 3
Journal homepage
33
Views
0
CrossRef citations to date
0
Altmetric
Letter

A case of active rheumatoid arthritis with renal dysfunction treated effectively with tocilizumab monotherapy

Takashi KatoDivision of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, 2-1 Kuratsuki-higashi, Kanazawa 920-8530, Japan;Division of Rheumatology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8641, JapanCorrespondence[email protected]
,
Ichiro KoniDivision of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, 2-1 Kuratsuki-higashi, Kanazawa 920-8530, Japan;Koni Clinic, 1-7 Midoridai, Uchinada-machi, Ishikawa 920-0276, Japan
,
Ryo InoueDivision of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, 2-1 Kuratsuki-higashi, Kanazawa 920-8530, Japan;Division of Rheumatology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8641, Japan
,
Susumu KitajimaDivision of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, 2-1 Kuratsuki-higashi, Kanazawa 920-8530, Japan;Division of Rheumatology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8641, Japan
,
Mitsuhiro KawanoDivision of Rheumatology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8641, Japan
&
Masakazu YamagishiDivision of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8641, Japan
Pages 316-318 | Received 18 Sep 2009, Accepted 26 Nov 2009, Published online: 02 Jan 2014

References

  • Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J, et al. Study of active controlled tocilizumab mono-therapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORD: significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Mod Rheumatol. 2009;19:12–9.
  • Koike R, Takeuchi T, Eguchi K, Miyasaka N. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol. 2007;17:451–8.
  • Koike R, Harigai M, Atsumi T, Amano K, Kawai S, Saito K, et al. Japanese College of Rheumatology 2009 guidelines for the use of tocifizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis. Mod Rheuamtol. 2009;19:351–7.
  • Nakamura M, Sakemi T, Nagasawa K. Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis. J Rheumatol. 1999;26(6):1424–5.
  • Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Com-parison of Disease Activity Score (DAS) 28-erythrocyte sedi-mentation rate and DAS 28-C-reactive protein threshold values. Ann Rheum Dis. 2007;66(3):407–9.
  • Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Ros-sert J, et al. Definition and classification of chronic kidney dis-ease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.
  • Sugioka Y, Inui K, Koike T. Use of etanercept in a patient with rheumatoid arthritis on hemodialysis. Mod Rheumatol. 2008;18:293–5.
  • Cho SK, Sung YK, Park S, Bae SC. Etanercept treatment in rheu-matoid arthritis patients with chronic kidney failure on predialysis. Rheumatol Int. 2009.
  • Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol. 2005;57:1407–13.
  • Jillella AP, Dainer PM, Kallab AM, Ustun C. Treatment of a patient with end-stage renal disease with Rituximab: pharmaco-kinetic evaluation suggests Rituximab is not eliminated by he-modialysis. Am J Hematol. 2002;71(3):219–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.